Rajnish Kumar

Redefining Alzheimer's disease diagnostics in the age of blood-based biomarkers.

Targeting DNA gyrase B: medicinal chemistry strategies to combat antimicrobial resistance.

This review comprehensively summarizes the design, synthesis, biological evaluation, and structure-activity relationships of heterocyclic GyrB inhibitors, highlighting the therapeutic potential of quinoline, thiazole, pyrrole, benzimidazole, benzofuran, azaindole, benzothiazole, pyrazole, pyridine, and related scaffold...

Therapeutic targeting of brain bioenergetics in Alzheimer's disease addressing insulin resistance, glucose hypometabolism, and mitochondrial dysfunction.

This chapter summarises the mechanistic framework linking bioenergetic breakdown to AD pathology, with potential therapeutic opportunities aimed at restoring mitochondrial function, enhancing glucose utilisation, and correcting insulin signalling, further opening new avenues for multimodal interventions and identificat...

A multistage computational pipeline integrating ligand-based and structure-based screening with ADMET evaluation, molecular dynamic simulation and free energy calculations for the discovery of potential TNIK inhibitors.

This LBVS-SBVS-ADMET-MD pipeline effectively identified three promising TNIK inhibitors, providing a solid foundation for future experimental validation and potential development of targeted therapies for Wnt-driven malignancies.